40
In band
Moving averages
SMA 200$23.86-5.28%
Company profile
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.
SectorHealthcare
IndustryBiotechnology
Market cap$947.70M
P/E ratioNone
EPS$-2.31
Beta1.338
Dividend yield0.00%
52-week high$37.48
52-week low$5.56
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
ARDX
Ardelyx Inc
RSI 37
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 52
GERN
Geron Corp
RSI 22
CADL
Candel Therapeutics Inc
RSI 38
GHRS
GH Research PLC
RSI 48
GPCR
Structure Therapeutics Inc
RSI 27
RSI alerts for ANRO
An email when ANRO closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:19 PM EDT